ERN ReCONNET

Team

Rosaria Talarico

Rosaria Talarico

Rosaria Talarico is the scientific coordinator of ERN ReCONNET since march 2017.

She is in charge of coordination of the research activities of ERN ReCONNET; methodological and strategic support to the ERN and to the other members of the Coordination team; management of the scientific publications of ERN ReCONNET; participation to the ERN Coordinators WGs; dupervision of the ERN activities on Clinical Practice Guidelines and Clinical Decision Making Tools. 

She is rheumatologist expert in rare and complex diseases and Coordinator of the Behçet Clinic Pisa in Rheumatology Unit (Azienda Ospedaliero Universitaria Pisana). She is also Assistant editor of Clinical and Experimental Rheumatology, Guest Editor of Frontier Medicine Rheumatology, and Guest Editor of Frontiers Young Minds.

 

 

 

Education and training

  • Morisky medication adherence and medication reconciliation licence (University of Pisa, Pisa)
  • Master Harvard Medical School “Global Clinical Scholars Research Training Program: Clinical Trial Concentration” (Harvard Medical School, Boston)
  • RARE-Best practices lnternational course “Health care guidelines on rare diseases: Quality assessment” (Italian National Institute of Health, Rome)
  • Master in Systematic Literature Reviews and Meta-analysis and guidelines production (ltalian Cochrane Centre, Istituto di Ricerche Farmacologiche Mario Negri, Milan)
  • Advanced Course “ClinicaI Experimentations” (Italian National Institute of Health, Rome)
  • PhD in Medical physiopathology and pharmacology (University di Pisa, Pisa)
  • Advanced course Epidemiological passe-partout for clinical research (National Research Centre, Pisa)
  • Intensive Course in Applied Epidemiology (University of Aberdeen, Aberdeen)
  • Advanced Course “Clinical Experimentation in paediatrics – Ethical aspects of clinical research in Paediatrics” (G. Gaslini lnstitute, Genoa)

Most relevant publications

  1. Marinello D, Del Bianco A, Manzo A, Mosca M, Talarico R. Empowering rare disease patients through patient education: the new BehçeTalk programme. BMC Rheumatol. 2022 Feb 28;6(1):17. doi: 10.1186/s41927-022-00247-1. PMID: 35220963.
  2. Marinello D, Di Cianni F, Del Bianco A, Mattioli I, Sota J, Cantarini L, Emmi G, Leccese P, Lopalco G, Mosca M, Padula A, Piga M, Salvarani C, Taruscio D, Talarico R. Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet’s Syndrome. Front Med (Lausanne). 2021 Dec 13;8:769870. doi: 10.3389/fmed.2021.769870. PMID: 34966756; PMCID: PMC8710680.
  3. Tani C, Pratesi F, Talarico R, Cardelli C, Caruso T, Di Cianni F, Laurino E, Italiano N, Moretti M, Manca ML, Migliorini P, Mosca M. Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies. RMD Open. 2021 Dec;7(3):e001914. doi: 10.1136/rmdopen-2021-001914. PMID: 34880126; PMCID: PMC8655339.
  4. Pirri S, Talarico R, Marinello D, Turchetti G, Mosca M. A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools. Reumatismo. 2021 Nov 22;73(3). doi: 10.4081/reumatismo.2021.1418. PMID: 34814655.
  5. Talarico R, Marinello D, Manzo A, Cannizzo S, Palla I, Ticciati S, Gaglioti A, Trieste L, Pisa L, Badalamenti L, Randisi G, Del Bianco A, Lorenzoni V, Turchetti G, Mosca M. Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey. Orphanet J Rare Dis. 2021 Oct 18;16(1):436. doi: 10.1186/s13023-021-02070-2. PMID: 34663419; PMCID: PMC8524918.
  6. Pirri S, Marinello D, Lorenzoni V, Andreozzi G, Bazzani A, Del Bianco A, Turchetti G, Mosca M, Talarico R. Adherence to treatment in Behçet’s syndrome: a multi-faceted issue. Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):88-93. Epub 2021 Sep 30. PMID: 34596034.
  7. Hatemi G, Seyahi E, Fresko I, Talarico R, Uçar D, Hamuryudan V. One year in review 2021: Behçet’s syndrome. Clin Exp Rheumatol. 2021 Sep-Oct;39 Suppl 132(5):3-13. Epub 2021 Sep 14. PMID: 34524077.
  8. Ferro F, Quartuccio L, Monti S, Delvino P, Di Cianni F, Fonzetti S, La Rocca G, Posarelli C, Treppo E, Talarico R, Baldini C. One year in review 2021: systemic vasculitis. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):3-12. Epub 2021 May 19. PMID: 34014159.
  9. Talarico R, Aguilera S, Alexander T, Amoura Z, Antunes AM, Arnaud L, Avcin T, Beretta L, Bombardieri S, Burmester GR, Cannizzo S, Cavagna L, Chaigne B, Cornet A, Costedoat-Chalumeau N, Doria A, Ferraris A, Fischer-Betz R, Fonseca JE, Frank C, Gaglioti A, Galetti I, Grunert J, Guimarães V, Hachulla E, Houssiau F, Iaccarino L, Krieg T, Limper M, Malfait F, Mariette X, Marinello D, Martin T, Matthews L, Matucci-Cerinic M, Meyer A, Montecucco C, Mouthon L, Müller-Ladner U, Rednic S, Romão VC, Schneider M, Smith V, Sulli A, Tamirou F, Taruscio D, Taulaigo AV, Terol E, Tincani A, Ticciati S, Turchetti G, van Hagen PM, van Laar JM, Vieira A, de Vries-Bouwstra JK, Cutolo M, Mosca M. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2021 Mar;17(3):177-184. doi: 10.1038/s41584-020-00565-z. Epub 2021 Jan 6. PMID: 33408338; PMCID: PMC7786339.
  10. Puxeddu I, Ferro F, Bartoloni E, Elefante E, Baldini C, Scirè C, Talarico R, Migliorini P, Mosca M, Bombardieri S. COVID-19: the new challenge for rheumatologists. One year later. Clin Exp Rheumatol. 2021 Jan-Feb;39(1):203-213. Epub 2021 Feb 5. PMID: 33555253.
  11. Talarico R, Cannizzo S, Lorenzoni V, Marinello D, Palla I, Pirri S, Ticciati S, Trieste L, Triulzi I, Terol E, Bucher A, Turchetti G. RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks. Orphanet J Rare Dis. 2020 Dec 14;15(1):347. doi: 10.1186/s13023-020-01631-1. Erratum in: Orphanet J Rare Dis. 2021 Mar 22;16(1):146. PMID: 33317578; PMCID: PMC7734838.
  12. Talarico R, Marinello D, Cannizzo S, Gaglioti A, Ticciati S, Carta C, Kodra Y, Azadegan M, Taruscio D, Mosca M, Turchetti G. Shaping the Future of Rare Diseases after a Global Health Emergency: Organisational Points to Consider. Int J Environ Res Public Health. 2020 Nov 23;17(22):8694. doi: 10.3390/ijerph17228694. PMID: 33238523; PMCID: PMC7700629.
  13. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2020: Behçet’s syndrome. Clin Exp Rheumatol. 2020 Sep-Oct;38 Suppl 127(5):3-10. Epub 2020 Dec 10. PMID: 33331271.
  14. Posarelli C, Maglionico MN, Talarico R, Covello G, Figus M. Behçet’s syndrome and ocular involvement: changes over time. Clin Exp Rheumatol. 2020 Sep-Oct;38 Suppl 127(5):86-93. Epub 2020 Nov 18. PMID: 33253088.
  15. Talarico R, Stagnaro C, Ferro F, Carli L, Mosca M. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. Lancet Rheumatol. 2020 Sep;2(9):e518-e519. doi: 10.1016/S2665-9913(20)30216-2. Epub 2020 Jul 13. PMID: 32838313; PMCID: PMC7357970.
  16. Talarico R, Marinello D, Bombardieri S, Burmester G, Fonseca J, Frank C, Galetti I, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, Smith V, Turchetti G, van Laar JM, Vieira A, Cutolo M, Mosca M. Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey. RMD Open. 2020 Aug;6(2):0. doi: 10.1136/rmdopen-2020-001344. PMID: 32868449; PMCID: PMC7507993.
  17. Fagni F, Bettiol A, Talarico R, Lopalco G, Silvestri E, Urban ML, Russo PAJ, Di Scala G, Emmi G, Prisco D. Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet’s phenotype: a multicentre study. Ann Rheum Dis. 2020 Aug;79(8):1098-1104. doi: 10.1136/annrheumdis-2020-217108. Epub 2020 May 7. PMID: 32381569.
  18. Ferro F, Elefante E, Puxeddu I, Baldini C, Bartoloni E, Baratè C, Galimberti S, Talarico R, Mosca M, Bombardieri S. COVID-19: the new challenge for rheumatologists. First update. Clin Exp Rheumatol. 2020 May-Jun;38(3):373-382. Epub 2020 May 26. PMID: 32452355.
  19. Ferro F, Elefante E, Baldini C, Bartoloni E, Puxeddu I, Talarico R, Mosca M, Bombardieri S. COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. Epub 2020 Mar 24. PMID: 32207680.
  20. Vitale A, Cavalli G, Ruscitti P, Sota J, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cavallaro E, Massaro MG, Cipriani P, De Marchi G, De Vita S, Emmi G, Frassi M, Gerli R, Gremese E, Iannone F, Fornaro M, Paladini A, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Frediani B, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Grosso S, Rigante D, Dagna L, Giacomelli R, Cantarini L. Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still’s Disease and Effect on Clinical and Laboratory Outcomes. Front Med (Lausanne). 2020 Feb 21;7:42. doi: 10.3389/fmed.2020.00042. PMID: 32154255; PMCID: PMC7047849.
  21. Talarico R, Elefante E, Parma A, Taponeco F, Simoncini T, Mosca M. Sexual dysfunction in Behçet’s syndrome. Rheumatol Int. 2020 Jan;40(1):9-15. doi: 10.1007/s00296-019-04455-w. Epub 2019 Oct 8. PMID: 31595309.
  22. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2019: Behçet’s syndrome. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):3-17. Epub 2019 Dec 9. PMID: 31856939.
  23. Posarelli C, Talarico R, Vella G, Passani A, Mosca M, Figus M. Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center. Clin Rheumatol. 2019 Oct;38(10):2917-2923. doi: 10.1007/s10067-019-04585-3. Epub 2019 Jun 6. PMID: 31172366.
  24. Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L. Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease. Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. PMID: 31507416; PMCID: PMC6715768.
  25. Posarelli C, Talarico R, Passani A, Mosca M, Nardi M, Figus M. Morphologic ultrasonography of the temporal artery for diagnosis of giant cell arteritis: Brief report. Mod Rheumatol. 2019 Jul;29(4):717-719. doi: 10.1080/14397595.2018.1504395. Epub 2018 Sep 13. PMID: 30041560.
  26. Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L. Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response. Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. PMID: 31001115; PMCID: PMC6454864.
  27. Monti S, Bond M, Felicetti M, Cavallaro E, Posarelli C, Elefante E, Ferro F, Talarico R, Quartuccio L, Baldini C. One year in review 2019: vasculitis. Clin  Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):3-19. Epub 2019 May 21. PMID: 31162034.
  28. Antunes M, Scirè CA, Talarico R, Alexander T, Avcin T, Belocchi C, Doria A, Franceschini F, Galetti I, Govoni M, Hachulla E, Launay D, Lepri G, Macieira C, Matucci-Cerinic M, Montecucco CM, Moraes-Fontes MF, Mouthon L, Paolino S, Ramoni V, Tani C, Tas SW, Tincani A, Van Vollenhoven R, Zen M, Fonseca J, Bombardieri S, Fonseca JE, Schneider M, Smith V, Cutolo M, Mosca M, Beretta L. Undifferentiated connective tissue disease: state of the art on clinical practice guidelines. RMD Open. 2019 Feb 26;4(Suppl 1):e000786. doi: 10.1136/rmdopen-2018-000786. PMID: 30886731; PMCID: PMC6397427.
  29. Meyer A, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Barsotti S, Beretta L, Blagojevic J, Burmester G, Cavazzana I, Cherrin P, Damian L, Doria A, Fonseca JE, Furini F, Galetti I, Houssiau F, Krieg T, Maddalena L, Launay D, Campanilho-Marques R, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Moraes-Fontes MF, Mouthon L, Neri R, Paolino S, Piette Y, Rednic S, Tamirou F, Tincani A, Toplak N, Bombardieri S, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Cavagna L. Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]. RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. Erratum in: RMD Open. 2019 Apr 15;5(1):e000784corr1. PMID: 30886730; PMCID: PMC6397434.
  30. Iaccarino L, Talarico R, Scirè CA, Amoura Z, Burmester G, Doria A, Faiz K, Frank C, Hachulla E, Hie M, Launay D, Montecucco C, Monti S, Mouthon L, Tincani A, Toniati P, Van Hagen PM, Van Vollenhoven RF, Bombardieri S, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Alexander T. IgG4-related diseases:  state of the art on clinical practice guidelines. RMD Open. 2019 Jan 19;4(Suppl 1):e000787. doi: 10.1136/rmdopen-2018-000787. PMID: 30729031; PMCID: PMC6341179.
  31. Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes- Fontes MF, Pamfil C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. PMID: 30564454; PMCID: PMC6269635.
  32. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2018: Behçet’s syndrome. Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):13-27. Epub 2018 Dec 13. PMID: 30582516.
  33. Talarico R, Palagini L, Elefante E, Ferro F, Tani C, Gemignani A, Bombardieri S, Mosca M. Behçet’s syndrome and psychiatric involvement: is it a primary or secondary feature of the disease? Clin Exp Rheumatol. 2018 Nov- Dec;36(6 Suppl 115):125-128. Epub 2018 Dec 13. PMID: 30582513.
  34. Sulli A, Talarico R, Scirè CA, Avcin T, Castori M, Ferraris A, Frank C, Grunert J, Paolino S, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Malfait F. Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(Suppl 1):e000790. doi: 10.1136/rmdopen-2018-000790. PMID: 30402275; PMCID: PMC6203099.
  35. Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, van Daele P, van Laar JM, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Mariette X. Sjögren’s syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(Suppl 1):e000789. doi: 10.1136/rmdopen-2018-000789. PMID: 30402274; PMCID: PMC6203093.
  36. Rednic S, Damian L, Talarico R, Scirè CA, Tobias A, Costedoat-Chalumeau N, Launay D, Mathian A, Mattews L, Ponte C, Toniati P, Bombardieri S, Frank C, Schneider M, Smith V, Cutolo M, Mosca M, Arnaud L. Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(Suppl 1):e000788. doi: 10.1136/rmdopen-2018-000788. PMID: 30402273; PMCID: PMC6203097.
  37. Limper M, Scirè CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N, Doria A, Dörner T, Fonseca JE, Galetti I, Hachulla E, Launay D, Lourenco F, Macieira C, Meroni P, Montecucco CM, Moraes-Fontes MF, Mouthon L, Nalli C, Ramoni V, Tektonidou M, van Laar JM, Bombardieri S, Schneider M, Smith V, Vieira A, Cutolo M, Mosca M, Tincani A. Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(Suppl 1):e000785. doi: 10.1136/rmdopen-2018-000785. PMID: 30402272; PMCID: PMC6203101.
  38. Chaigne B, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Beretta L, Doria A, Guffroy A, Guimarães V, Hachulla É, Krieg T, Launay D, Lepri G, Moinzadeh P, Müller-Ladner U, Rednic S, Rodrigues A, Tas SW, van Vollenhoven RF, Vieira A, Bombardieri S, Fonseca JE, Galetti I, Schneider M, Smith V, Cutolo M, Mosca M, Fischer-Betz R. Mixed connective tissue disease: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(Suppl 1):e000783. doi: 10.1136/rmdopen-2018-000783. PMID: 30402271; PMCID: PMC6203102.
  39. Smith V, Scirè CA, Talarico R, Airo P, Alexander T, Allanore Y, Bruni C, Codullo V, Dalm V, De Vries-Bouwstra J, Della Rossa A, Distler O, Galetti I, Launay D, Lepri G, Mathian A, Mouthon L, Ruaro B, Sulli A, Tincani A, Vandecasteele E, Vanhaecke A, Vanthuyne M, Van den Hoogen F, Van Vollenhoven R, Voskuyl AE, Zanatta E, Bombardieri S, Burmester G, Eurico FJ, Frank C, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, van Laar JM, Vieira A, Cutolo M, Mosca M, Matucci-Cerinic M. Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open. 2018 Oct 18;4(Suppl 1):e000782. doi: 10.1136/rmdopen-2018-000782. PMID: 30402270; PMCID: PMC6203100.
  40. Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology). Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real- life clinical practice: a nationwide multicenter retrospective observational study. Clin Rheumatol. 2018 Aug;37(8):2233-2240. doi: 10.1007/s10067-018-4119-x. Epub 2018 May 17. PMID: 29770930.
  41. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2017: Behçet’s syndrome. Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):3-15. Epub 2017 Sep 29. PMID: 28980900.
  42. Ferro F, Elefante E, Luciano N, Talarico R, Todoerti M. One year in review 2017: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2017 Sep-Oct;35(5):721-734. Epub 2017 Sep 13. PMID: 28956527.
  43. Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cantarini L, Cavallaro E, Cavalli G, Cerrito L, Cipriani P, Dagna L, Marchi G, Vita S, Emmi G, Ferraccioli G, Frassi M, Galeazzi M, Gerli R, Giacomelli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Ruscitti P, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Fabris F, Bindoli S, Punzi L, Galozzi P, Sfriso P. Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study. Front Pharmacol. 2017 Jun 13;8:369. doi: 10.3389/fphar.2017.00369. PMID: 28659802; PMCID: PMC5469286.
  44. Elefante E, Monti S, Bond M, Lepri G, Quartuccio L, Talarico R, Baldini C. One year in review 2017: systemic vasculitis. Clin Exp Rheumatol. 2017 Mar- Apr;35 Suppl 103(1):5-26. Epub 2017 Mar 29. PMID: 28375840.
  45. Parma A, Cometi L, Leone MC, Lepri G, Talarico R, Guiducci S. One year in review 2016: spondyloarthritis. Clin Exp Rheumatol. 2017 Jan-Feb;35(1):3-17. Epub 2017 Jan 26. PMID: 28150582.
  46. Talarico R, Barsotti S, Elefante E, Baldini C, Tani C, Mosca M. Systemic vasculitis and the lung. Curr Opin Rheumatol. 2017 Jan;29(1):45-50. doi: 10.1097/BOR.0000000000000342. PMID: 27755177.
  47. Cantarini L, Talarico R, Generali E, Emmi G, Lopalco G, Costa L, Silvestri E, Caso F, Franceschini R, Cimaz R, Iannone F, Galeazzi M, Selmi C. Safety profile of biologic agents for Behçet’s disease in a multicenter observational cohort study. Int J Rheum Dis. 2017 Jan;20(1):103-108. doi: 10.1111/1756-185X.12732. Epub 2015 Aug 18. PMID: 26284332.
  48. Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, Gentileschi S, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Rigante D, Cantarini L. A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. Front Pharmacol. 2016  Oct 24;7:380. doi: 10.3389/fphar.2016.00380. PMID: 27822185; PMCID: PMC5076463.
  49. Barsotti S, Zampa V, Talarico R, Minichilli F, Ortori S, Iacopetti V, D’ascanio A, Tavoni AG, Bombardieri S, Mosca M, Neri R. Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center. Muscle Nerve. 2016 Oct;54(4):666-72. doi: 10.1002/mus.25099. Epub 2016 Jun 9. PMID: 27279002.
  50. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2016: Behçet’s syndrome. Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):10-22. Epub 2016 Oct 13. PMID: 27791958.
  51. Calabrò A, Caterino AL, Elefante E, Valentini V, Vitale A, Talarico R, Cantarini L, Frediani B. One year in review 2016: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016 May-Jun;34(3):357-72. Epub 2016 May 30. PMID: 27268779.
  52. Cantarini L, Pucino V, Vitale A, Talarico R, Lucherini OM, Magnotti F, De Rosa V, Galgani M, Alviggi C, Marone G, Galeazzi M, Matarese G. Immunometabolic biomarkers of inflammation in Behçet’s disease: relationship with epidemiological profile, disease activity and therapeutic regimens. Clin Exp Immunol. 2016 May;184(2):197-207. doi: 10.1111/cei.12768. Epub 2016 Feb 24. PMID: 26756979; PMCID: PMC4837234.
  53. Pucino V, Lucherini OM, Perna F, Obici L, Merlini G, Cattalini M, La Torre F, Maggio MC, Lepore MT, Magnotti F, Galgani M, Galeazzi M, Marone G, De Rosa V, Talarico R, Cantarini L, Matarese G. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome. J Leukoc Biol. 2016 May;99(5):761-9. doi: 10.1189/jlb.3A0915-399R. Epub 2015 Nov 23. PMID: 26598380.
  54. Emmi G, Talarico R, Lopalco G, Cimaz R, Cantini F, Viapiana O, Olivieri I, Goldoni M, Vitale A, Silvestri E, Prisco D, Lapadula G, Galeazzi M, Iannone F, Cantarini L. Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study. Clin Rheumatol. 2016 May;35(5):1281-6. doi: 10.1007/s10067-015-3004-0. Epub 2015 Jul 10. PMID: 26156661.
  55. Talarico R, Cantarini L, d’Ascanio A, Figus M, Favati B, Baldini C, Tani C, Neri R, Bombardieri S, Mosca M. Development of de novo major involvement during follow-up in Behçet’s syndrome. Clin Rheumatol. 2016 Jan;35(1):247-50. doi: 10.1007/s10067-015-2906-1. Epub 2015 Mar 8. PMID: 25750177.
Subscribe to our Newsletter